Panacea Life Sciences Holdings, Inc. Proceeds from Sale and Maturity of Marketable Securities
Panacea Life Sciences Holdings, Inc. (PLSH) reported Proceeds from Sale and Maturity of Marketable Securities of $46.83 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-04-01.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2024-04-01
- Panacea Life Sciences Holdings, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2022-12-31 was $0.00.
- Panacea Life Sciences Holdings, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2022-09-30 was $0.00.
- Panacea Life Sciences Holdings, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2021-12-31 was $0.00.
- Panacea Life Sciences Holdings, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2014-12-31 was $0.00.
- Panacea Life Sciences Holdings, Inc. proceeds from sale and maturity of marketable securities for fiscal 2022 was $46.83K, a 79.66% decline from fiscal 2021.
- Panacea Life Sciences Holdings, Inc. proceeds from sale and maturity of marketable securities for fiscal 2021 was $230.30K.
- Panacea Life Sciences Holdings, Inc. proceeds from sale and maturity of marketable securities for fiscal 2014 was $165.33K.
| Period end | Proceeds from Sale and Maturity of Marketable Securities 3 month | Proceeds from Sale and Maturity of Marketable Securities 6 month | Proceeds from Sale and Maturity of Marketable Securities 9 month | Proceeds from Sale and Maturity of Marketable Securities 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $0.00 derived: sum of 2 quarters · filed 2024-04-01 | $46.83K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $46.83K 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $46.83K 10-Q · filed 2023-08-15 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $230.30K 10-K · filed 2023-03-30 | ||
| 2021-09-30 | $230.30K 10-Q · filed 2022-11-14 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $0.00 derived: sum of 2 quarters · filed 2016-02-29 | $165.33K 10-K · filed 2016-02-29 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $165.33K 10-Q · filed 2015-11-06 | ||
| 2014-06-30 | $165.33K 10-Q · filed 2015-08-06 |